#IBRX FDA Expands ANKTIVA® Approval for BCG-Unresponsive Non-Muscle-Invasive Bladder Cancer to Cover Both Papillary and CIS Disease

https://www.stocktitan.net/news/IBRX/fda-expands-anktiva-approval-for-bcg-unresponsive-non-muscle-7jvyxd0na4np.html?utm_source=stocktitan-bluesky&utm_medium=social

Rep. Lisa Mcclain (R-MI) disclosed 2 trades:
Traded: Sep 28 | Disclosed: Oct 12

Bought: $IBRX ($1K-$15K), $CAT ($1K-$15K)

https://integrityindex.us/candidate/lisa-mcclain

Rep. Lisa Mcclain (R-MI) disclosed 3 trades:
Traded: Sep 30 | Disclosed: Oct 12

Bought: $MSFT ($1K-$15K), $IBRX ($1K-$15K)
Sold: $STX ($15K-$50K)

https://integrityindex.us/candidate/lisa-mcclain

New House STOCK Act disclosure: Lisa McClain reported a purchase of SP ImmunityBio, Inc. - Common Stock (IBRX) [ST]. Amount: $1,001 - $15,000. Transaction date: 2026-09-30. Filed:...

https://www.narrowit.com/politics-trading/5cdce355a328e46286fb
#CongressTrading #StockAct #House #IBRX #HousePtr

InsiderFinance's AI analysis flagged #IBRX at $8.75. The Long Call later ran +23.54% in 10 trading days.
↗️ Week flow: $7.10M calls vs $2.07M puts
↗️ Block call: $7.5 Call 2028-01-21 led with $3.11M
➡️ Level: $10 handle into next week

#IBRX ImmunityBio to Participate in the Piper Sandler Virtual Oncology Symposium

https://www.stocktitan.net/news/IBRX/immunity-bio-to-participate-in-the-piper-sandler-virtual-oncology-0xl7vw0unht2.html?utm_source=stocktitan-bluesky&utm_medium=social

📄 $IBRX 10-Q — what changed
MD&A now says: "Forward-looking statements include, but are not limited to: • our ability to successfully commercialize ANKTIVA globally in current and future approved indications (including NMIBC and NSCLC), and to obtain incremental regulatory approvals for new i

🔴 $IBRX — Cohen Cheryl, Director
SOLD: 81,056 shares @ $10.50
Total: $851K
Filed Oct 1, 2026 · 8:00pm ET
📈 History & trend → https://www.formdelta.com/ticker/IBRX

#InsiderTrading #IBRX #StockMarket

🔴 $IBRX — Simon Barry J., Director
SOLD: 25,000 shares @ $10.75
Total: $269K
Filed Oct 4, 2026 · 8:00pm ET
📈 History & trend → https://www.formdelta.com/ticker/IBRX

#InsiderTrading #IBRX #StockMarket

InsiderFinance's AI analysis handed members #IBRX Long Call at $8.75. +20.57% in 5 trading days.
↗️ $7.24M calls vs $2.64M puts
↘️ $10 Put 2028-01-21, 3,241 contracts vs 497 OI
➡️ Watch level: $9-$10 zone

InsiderFinance's AI analysis featured this exact #IBRX Long Call. Already +15.31% in 3 trading days.
↗️ 5D premium: $7.999M calls vs $1.541M puts
↗️ Fresh upside: $12 Call 3,288 contracts vs 2,193 OI
➡️ Watch: $8.75 spot; above it calls stay in play, below it the $9 put matters